Pembrolizumab and salvage chemotherapy in EGFR T790M-positive non-small-cell lung cancer with high PD-L1 expression

Immuno-checkpoint inhibitors (ICI) have become an effective treatment option for non-small-cell lung cancer patients. However, ICI therapy was reported to be less effective in patients with epidermal growth factor receptor (EGFR) mutations than in those with wild-type EGFR. We report here that an no...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Onco Targets Ther
Autors principals: Tozuka, Takehiro, Seike, Masahiro, Minegishi, Yuji, Kitagawa, Shingo, Kato, Tomomi, Takano, Natsuki, Hisakane, Kakeru, Takahashi, Satoshi, Kobayashi, Kenichi, Kashiwada, Takeru, Sugano, Teppei, Takeuchi, Susumu, Kunugi, Shinobu, Noro, Rintaro, Saito, Yoshinobu, Kubota, Kaoru, Gemma, Akihiko
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2018
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6135433/
https://ncbi.nlm.nih.gov/pubmed/30237726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S168598
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars